enasidenib
bms
['leusm', 'idhentify']
#asco22 #leusm de botton: outcomes by idh2 allele (r140 vs r172) on idhentify trial. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)